Wed, October 13, 2021
Tue, October 12, 2021
Mon, October 11, 2021

David Lebowitz Maintained (SNDX) at Hold with Increased Target to $21 on, Oct 12th, 2021

David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Increased Target from $20 to $21 on, Oct 12th, 2021.

David, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30